NO954913L - Nye heterocykliske amider - Google Patents
Nye heterocykliske amiderInfo
- Publication number
- NO954913L NO954913L NO954913A NO954913A NO954913L NO 954913 L NO954913 L NO 954913L NO 954913 A NO954913 A NO 954913A NO 954913 A NO954913 A NO 954913A NO 954913 L NO954913 L NO 954913L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- branched
- heterocyclic amides
- straight
- chain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/36—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Abstract
Det er beskrevet heterocykliske amider med formelen O A¿Z--A,- M OR, R, R. hvori A kan ha flere betydninger og blant annet bety en aromatisk eller S- eller N-heteroaromatlsk ring med 5- 10 C-atomer som eventuelt kan være substituert. Z betyr restene C-0, SO eller S02 og A^ betyr et heteroaroma- tisk system inneholdende S og eventuelt N, R! og ~&2 betyr uavhengig av hverandre H, rettkjedet eller forgrenet C^-C^alkyl eller fluorert alkyl , og R3 betyr H, rettkjedet eller forgrenet C1-C4-alkyl , acetyl, alkylacetyl eller en under fysiologiske betingelser avspaltbar gruppe. Det er videre beskrevet en fremgangsmåte for frem- stilling av disse amldene samt deres anvendelse som virksomme stoffer for helbredelse og lindring av sykdommer og forstyrrelser som kan behandles ved påvirkning av kaliumkanalene.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0225294A AT402926B (de) | 1994-12-05 | 1994-12-05 | Heterocyclische amide, verfahren zu ihrer herstellung und verwendung |
Publications (2)
Publication Number | Publication Date |
---|---|
NO954913D0 NO954913D0 (no) | 1995-12-04 |
NO954913L true NO954913L (no) | 1996-06-06 |
Family
ID=3530873
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO954913A NO954913L (no) | 1994-12-05 | 1995-12-04 | Nye heterocykliske amider |
Country Status (15)
Country | Link |
---|---|
US (1) | US5627198A (no) |
EP (1) | EP0716087A1 (no) |
JP (1) | JPH08225553A (no) |
CN (1) | CN1132204A (no) |
AT (1) | AT402926B (no) |
AU (1) | AU4021595A (no) |
CA (1) | CA2164375A1 (no) |
CZ (1) | CZ321695A3 (no) |
FI (1) | FI955818A (no) |
HU (1) | HUT75064A (no) |
IL (1) | IL116245A0 (no) |
NO (1) | NO954913L (no) |
NZ (1) | NZ280589A (no) |
SK (1) | SK151395A3 (no) |
ZA (1) | ZA9510305B (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6407124B1 (en) | 1998-06-18 | 2002-06-18 | Bristol-Myers Squibb Company | Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
TWI271402B (en) * | 2002-10-15 | 2007-01-21 | Tanabe Seiyaku Co | Large conductance calcium-activated K channel opener |
DK2528621T3 (da) | 2010-01-27 | 2017-01-02 | Glaxosmithkline Biologicals Sa | Modificerede tuberkuloseantigener |
CN110117263B (zh) * | 2019-06-11 | 2020-12-25 | 湖南中医药大学 | 2-氨基-5-酰基噻唑衍生物及其合成方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3051M (fr) * | 1963-11-15 | 1965-01-04 | Bruneau & Cie Lab | Médicament a base de dérivé de thiadiazol. |
TW205041B (no) * | 1989-08-07 | 1993-05-01 | Fujisawa Pharmaceutical Co | |
GB9214120D0 (en) * | 1991-07-25 | 1992-08-12 | Ici Plc | Therapeutic amides |
GB9305295D0 (en) * | 1993-03-15 | 1993-05-05 | Zeneca Ltd | Therapeutic compounds |
-
1994
- 1994-12-05 AT AT0225294A patent/AT402926B/de not_active IP Right Cessation
-
1995
- 1995-11-24 EP EP95118497A patent/EP0716087A1/de not_active Withdrawn
- 1995-11-30 SK SK1513-95A patent/SK151395A3/sk unknown
- 1995-12-04 US US08/567,057 patent/US5627198A/en not_active Expired - Fee Related
- 1995-12-04 JP JP7315358A patent/JPH08225553A/ja not_active Withdrawn
- 1995-12-04 AU AU40215/95A patent/AU4021595A/en not_active Abandoned
- 1995-12-04 CN CN95120215A patent/CN1132204A/zh active Pending
- 1995-12-04 FI FI955818A patent/FI955818A/fi not_active Application Discontinuation
- 1995-12-04 IL IL11624595A patent/IL116245A0/xx unknown
- 1995-12-04 HU HU9503466A patent/HUT75064A/hu unknown
- 1995-12-04 NZ NZ280589A patent/NZ280589A/en unknown
- 1995-12-04 NO NO954913A patent/NO954913L/no unknown
- 1995-12-04 CA CA002164375A patent/CA2164375A1/en not_active Abandoned
- 1995-12-05 CZ CZ953216A patent/CZ321695A3/cs unknown
- 1995-12-05 ZA ZA9510305A patent/ZA9510305B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
SK151395A3 (en) | 1996-06-05 |
HU9503466D0 (en) | 1996-01-29 |
US5627198A (en) | 1997-05-06 |
ZA9510305B (en) | 1996-06-11 |
NO954913D0 (no) | 1995-12-04 |
IL116245A0 (en) | 1996-03-31 |
ATA225294A (de) | 1997-02-15 |
NZ280589A (en) | 1996-08-27 |
CN1132204A (zh) | 1996-10-02 |
EP0716087A1 (de) | 1996-06-12 |
JPH08225553A (ja) | 1996-09-03 |
AU4021595A (en) | 1996-06-13 |
FI955818A0 (fi) | 1995-12-04 |
FI955818A (fi) | 1996-06-06 |
AT402926B (de) | 1997-09-25 |
HUT75064A (en) | 1997-03-28 |
CA2164375A1 (en) | 1996-06-06 |
CZ321695A3 (en) | 1996-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20003514L (no) | Hypolipidemiske benzothiazepin-forbindelser | |
NO941937D0 (no) | Sakarinderivater som inhiberer proteolytiske enzymer | |
ES2081927T3 (es) | Metodo de revitalizar celulas antes de la crioconservacion. | |
IL104154A0 (en) | Saccharin derivatives,their preparation and pharmaceutical compositions containing them | |
DK165406C (da) | Substituerede n-(2,4,6-trimethoxyphenyl)-fedtsyreamider, fremgangsmaade til fremstilling deraf, farmaceutisk praeparat indeholdende disse forbindelser samt anvendelse af disse forbindelser til fremstilling af et farmaceutisk praeparat til inhibering af intestinal absorption af kolesterol | |
NO905608D0 (no) | Fremgangsmaate for fremstilling av a-nor-steroid-3-karboksylsyrederivater. | |
PT95389A (pt) | Processo para a preparacao de novos derivados pirazolicos com accao anti-inflamatoria | |
DK653688A (da) | Stabiliserede laegemiddelaktive forbindelser, fremgangsmaade til deres frmstilling samt stabile laegemiddelpraeparater | |
NO903438L (no) | Fremgangsmaate for fremstilling av tiazolderivater. | |
MY132473A (en) | Crystalline hydrochloride of (r)-(-)-2-<n-[4-(1,1- dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl]-aminomethyl>-chroman | |
DK162883D0 (da) | N-glucosylerede carboxylsyreamidderivater, fremgangsmade til fremstilling heraf samt deres anvendelse til pavirkning af organismens egen forsvarsmekanisme | |
EP0471756A4 (en) | Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof | |
DK0404283T3 (da) | 11alfa-aryl-4-estrener, fremgangsmåde til fremstilling af disse samt deres anvendelse som lægemidler | |
NO954913L (no) | Nye heterocykliske amider | |
HU910784D0 (en) | Process for producing new urea derivatives as well as pharmaceutical preparatives containing these compounds as active substance | |
DK0998471T3 (da) | Heterocykliske forbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, som indeholder disse | |
HU896775D0 (en) | Fungicid compositions comprising sulfurous oximethers as active ingredient and process for preparation thereof | |
EP0162715A3 (en) | Enzyme-inhibitory griseolic acid derivatives, and their use | |
NO985974L (no) | Piperidineddiksyrederivater og deres anvendelse ved behandling av trombose-sykdommer | |
PT82550B (pt) | Processo de preparacao de derivados de 1,3-oxatiano e de composicoes farmaceuticas que os contem | |
IT1230140B (it) | Derivati della serina, loro processo di preparazione e impiego in terapia umana | |
NO963374L (no) | Substituerte 4H-pyraner | |
NO153005C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive, fluorerte diamino-heptynderivater. | |
ES490814A0 (es) | Procedimiento para la preparacion de un derivado de acido 5-(2-(2,3-dihidro-1,4-benzodioxan-2-ilmetil)amino)-1-hidroxie-til)-2-hidroxibenzoico | |
DK27081A (da) | Indan-4-yl-n-alkyl-carbaminsyreestere,fremgangsmaade til fremstilling heraf samt deres anvendelse som fungicider |